calendar
9,516 catalysts · 3,345 8k filing · 2,032 grant · 1,000 device adverse event · 910 approval · 674 device 510k · 584 earnings
next 91 dayslessmore
MonWedFri
9,516 catalysts · 3,345 8k filing · 2,032 grant · 1,000 device adverse event · 910 approval · 674 device 510k · 584 earnings
Product code: KCT. Advisory committee: General Hospital. Type: Traditional
Product code: FYA. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: OBR. Advisory committee: Unknown. Type: Traditional
Product code: OSN. Advisory committee: Orthopedic. Type: Traditional
Product code: QSY. Advisory committee: Unknown. Type: Traditional
Product code: FLE. Advisory committee: General Hospital. Type: Traditional
Supplement type: 30-Day Notice. Product code: NPT. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MCX. Advisory committee: CV. Decision: OK30
Supplement type: Real-Time Process. Product code: ONV. Advisory committee: SU. Decision: APPR
Supplement type: Real-Time Process. Product code: LKK. Advisory committee: HO. Decision: APPR
Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30
Supplement type: Normal 180 Day Track. Product code: QPY. Advisory committee: PM. Decision: APPR
Supplement type: 30-Day Notice. Product code: SGV. Advisory committee: SU. Decision: OK30
Supplement type: Special (Immediate Track). Product code: OAY. Advisory committee: GU. Decision: APPR
Product code: MJO. Advisory committee: OR. Decision: APPR
AI grant. $111,645. PI: Ruvandhi Nathavitharana
GM grant. $400,881. PI: Tomer Stern
GM grant. $402,051. PI: CARLITO B LEBRILLA
Sponsor: JANSSEN PRODS. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: VALEANT LUXEMBOURG. Form: INJECTABLE. Route: INJECTION
Sponsor: JAZZ. Form: POWDER. Route: INTRAVENOUS
Sponsor: BIOMARIN PHARM. Form: INJECTABLE. Route: INJECTION
Sponsor: HUMANWELL PURACAP. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PRODS. Form: TABLET. Route: ORAL
Sponsor: ALMATICA. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ASTELLAS. Form: SOLUTION. Route: INTRAVITREAL
Sponsor: CELGENE CORP. Form: POWDER. Route: SUBCUTANEOUS
Sponsor: ASCENDIS. Form: POWDER. Route: SUBCUTANEOUS
Sponsor: CUBIST PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: CUBIST PHARMS LLC. Form: POWDER. Route: INTRAVENOUS
Sponsor: CAPLIN. Form: INJECTABLE. Route: INJECTION
Product code: HRS. Advisory committee: Orthopedic. Type: Traditional
Product code: CIG. Advisory committee: Clinical Chemistry. Type: Traditional
Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: QIH. Advisory committee: Radiology. Type: Traditional
Product code: MVL. Advisory committee: Unknown. Type: Traditional
Product code: DQA. Advisory committee: Cardiovascular. Type: Traditional
Product code: LFD. Advisory committee: Unknown. Type: Traditional
Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: GCJ. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: MBI. Advisory committee: Orthopedic. Type: Traditional
Product code: ETN. Advisory committee: Ear, Nose, Throat. Type: Traditional
Product code: DXF. Advisory committee: Cardiovascular. Type: Special
Supplement type: Real-Time Process. Product code: NQR. Advisory committee: NE. Decision: APPR
Supplement type: 30-Day Notice. Product code: LGW. Advisory committee: NE. Decision: OK30
Supplement type: 30-Day Notice. Product code: QYI. Advisory committee: CV. Decision: OK30